Skip to main content

Phibro Animal Health Corporation

corporate_fare Company Profile

Phibro Animal Health Corporation

PAHC·NASDAQ·Life Sciences·CIK 0001069899

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It partners with livestock producers, farmers, veterinarians, and consumers to provide solutions for maintaining and enhancing animal health. The company markets approximately 790 product lines in approximately 90 countries to approximately 4,800 customers. Phibro develops, manufactures, and markets a broad range of products for food animals, including poultry, beef and dairy cattle, swine, aquaculture, and dogs, which help prevent, control, and treat diseases and support nutrition. Products are sold directly to integrated poultry, cattle, and swine producers, or through animal feed manufacturers, wholesalers, distributors, and veterinarians. Key offerings include Animal Health products such as antibacterials, anticoccidials, nutritional specialty products, and vaccines and vaccine adjuvants, which improve animal health, performance, food safety, and welfare. The Animal Health segment also includes antibacterials and other processing aids for the ethanol fermentation industry. Mineral nutrition products fortify animal diets and help maintain optimal health. Phibro focuses on regions with consolidated livestock production in large commercial farms, with established sales, marketing, and distribution networks in North America, Latin America, Asia Pacific, Europe, Africa, and the Middle East. While currently concentrated in the livestock sector, the company is investing in companion animal products. Additionally, Phibro manufactures and markets specific ingredients for the personal care, industrial chemical, and chemical catalyst industries, selling these performance products directly to customers. The company's Class A common stock trades on Nasdaq under the symbol "PAHC."

Phibro Animal Health Corporation (NASDAQ:PAHC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for PAHC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for PAHC spans 8-K, 10-K, SCHEDULE 13D/A, 10-Q.

Recent high-impact activity:

  • Phibro Q1 Sales Rise 6% to $386.8M, FY2027 Guidance Held
  • Phibro Sets FY2027 Targets: $1.55B-$1.60B Sales, $258M-$268M Adjusted EBITDA; Chicago Heights Plant to Close
  • Phibro Animal Health Posts Record FY2026 Sales, Guides FY2027 Above Consensus
  • Phibro FY2026: Net Income Doubles to $99.7M on Zoetis MFA Integration; Chicago Heights Plant to Close
  • Phibro Animal Health Appoints Daniel Bendheim as CEO, Grants Performance-Based RSUs with Aggressive Stock Price Targets

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$1.52B
Net Income
$99.72M
Diluted EPS
$2.43
Op. Cash Flow
$68.95M
Free Cash Flow
$9.87M
Gross Profit
$512.51M
Operating Income
$194.4M
Cash & Equivalents
$61.42M
Debt / Equity
0.00×
Net Margin
6.6%
Shares Outstanding
40.55M sh
Source: 10-K · filed 2026-08-26 · accession 0001104659-26-101493

Short Interest & Short Volume

6.42 days to cover

FINRA reported short interest of 1,019,391 shares in PAHC as of the October 30, 2026 settlement, a 1.3% decrease from the prior period — about 6.4 days to cover at its recent average daily volume. On November 19, 2026, 45.8% of PAHC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,019,391 shares as of October 30, 2026
Change vs prior period▼ 1.3%
Days to cover6.42 at avg daily volume of 158,839
Daily short volume (FINRA facilities)45.8% of 37,242 shares on November 19, 2026
5-day average short volume56.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with P →
$33.34 -2.17% today
52-week range · as of 2026-08-26 $28.25 – $60.08
Market cap
$1.35B
Volume
112.3K (0.6× avg)
3-mo avg 200.1K
Live data · 2026-11-20 21:01 UTC · After hours

show_chartPrice Chart

Loading chart...

feed PAHC - Latest Insights

PAHC
Nov 04, 2026, 4:22 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $39.32
Real-time Price: $33.34 info
Change: -$5.98 (-15%) info
Market Cap: $1.354B info
PAHC
Aug 26, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.93
Real-time Price: $33.34 info
Change: -$2.59 (-7%) info
Market Cap: $1.354B info
PAHC
Aug 26, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $35.93
Real-time Price: $33.34 info
Change: -$2.59 (-7%) info
Market Cap: $1.354B info
PAHC
Aug 26, 2026, 4:14 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $35.93
Real-time Price: $33.34 info
Change: -$2.59 (-7%) info
Market Cap: $1.354B info
PAHC
Jun 26, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.69
Real-time Price: $33.34 info
Change: +$1.65 (+5%) info
Market Cap: $1.354B info
PAHC
May 22, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $33.26
Real-time Price: $33.34 info
Change: +$0.080 (+0.24%) info
Market Cap: $1.354B info
PAHC
May 06, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $58.50
Real-time Price: $33.34 info
Change: -$25.16 (-43%) info
Market Cap: $1.354B info
PAHC
May 06, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $55.08
Real-time Price: $33.34 info
Change: -$21.74 (-39%) info
Market Cap: $1.354B info
PAHC
May 06, 2026, 4:25 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $57.00
Real-time Price: $33.34 info
Change: -$23.66 (-42%) info
Market Cap: $1.354B info
PAHC
Apr 30, 2026, 4:26 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $53.18
Real-time Price: $33.34 info
Change: -$19.84 (-37%) info
Market Cap: $1.354B info
PAHC
Apr 27, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $56.14
Real-time Price: $33.34 info
Change: -$22.80 (-41%) info
Market Cap: $1.354B info
PAHC
Apr 23, 2026, 8:36 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $54.69
Real-time Price: $33.34 info
Change: -$21.35 (-39%) info
Market Cap: $1.354B info
PAHC
Feb 04, 2026, 4:41 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $45.38
Real-time Price: $33.34 info
Change: -$12.04 (-27%) info
Market Cap: $1.354B info
PAHC
Feb 04, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $41.00
Real-time Price: $33.34 info
Change: -$7.66 (-19%) info
Market Cap: $1.354B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets